Kardoust Parizi M - Search Results

1

Comparing the Performance of Digital Rectal Examination and Prostate-specific Antigen as a Screening Test for Prostate Cancer: A Systematic Review and Meta-analysis.

Matsukawa A, Yanagisawa T, Bekku K, Kardoust Parizi M, Laukhtina E, Klemm J, Chiujdea S, Mori K, Kimura S, Fazekas T, Miszczyk M, Miki J, Kimura T, Karakiewicz PI, Rajwa P, Shariat SF. Matsukawa A, et al. Among authors: kardoust parizi m. Eur Urol Oncol. 2024 Aug;7(4):697-704. doi: 10.1016/j.euo.2023.12.005. Epub 2024 Jan 4. Eur Urol Oncol. 2024. PMID: 38182488 Free article.

2

Focal Neuroendocrine Differentiation of Conventional Prostate Adenocarcinoma as a Prognostic Factor after Radical Prostatectomy: A Systematic Review and Meta-Analysis.

Kardoust Parizi M, Iwata T, Kimura S, Janisch F, Abufaraj M, Karakiewicz PI, Enikeev D, Rapoport LM, Hutterer G, Shariat SF. Kardoust Parizi M, et al. Int J Mol Sci. 2019 Mar 19;20(6):1374. doi: 10.3390/ijms20061374. Int J Mol Sci. 2019. PMID: 30893781 Free PMC article.

3

Risk stratification of upper tract urothelial carcinoma: A Review of the Current Literature.

Kardoust Parizi M, Glybochko PV, Enikeev D, Rouprêt M, Fajkovic H, Seebacher V, Shariat SF. Kardoust Parizi M, et al. Expert Rev Anticancer Ther. 2019 Jun;19(6):503-513. doi: 10.1080/14737140.2019.1621753. Epub 2019 May 27. Expert Rev Anticancer Ther. 2019. PMID: 31131643 Review.

4

Oncological safety of testosterone replacement therapy in prostate cancer survivors after definitive local therapy: A systematic literature review and meta-analysis.

Kardoust Parizi M, Abufaraj M, Fajkovic H, Kimura S, Iwata T, D'Andrea D, Karakiewicz PI, Shariat SF. Kardoust Parizi M, et al. Urol Oncol. 2019 Oct;37(10):637-646. doi: 10.1016/j.urolonc.2019.06.007. Epub 2019 Jul 8. Urol Oncol. 2019. PMID: 31296421

5

Prognostic value of T1 substaging on oncological outcomes in patients with non-muscle-invasive bladder urothelial carcinoma: a systematic literature review and meta-analysis.

Kardoust Parizi M, Enikeev D, Glybochko PV, Seebacher V, Janisch F, Fajkovic H, Chłosta PL, Shariat SF. Kardoust Parizi M, et al. World J Urol. 2020 Jun;38(6):1437-1449. doi: 10.1007/s00345-019-02936-y. Epub 2019 Sep 6. World J Urol. 2020. PMID: 31493109 Free PMC article.

6

The value and limitations of urothelial bladder carcinoma molecular classifications to predict oncological outcomes and cancer treatment response: A systematic review and meta-analysis.

Kardoust Parizi M, Margulis V, Compe Rat E, Shariat SF. Kardoust Parizi M, et al. Urol Oncol. 2021 Jan;39(1):15-33. doi: 10.1016/j.urolonc.2020.08.023. Epub 2020 Sep 6. Urol Oncol. 2021. PMID: 32900624

7

Value of tumour-infiltrating immune cells in predicting response to intravesical BCG in patients with non-muscle-invasive bladder cancer: a systematic review and meta-analysis.

Kardoust Parizi M, Shariat SF, Margulis V, Mori K, Lotan Y. Kardoust Parizi M, et al. BJU Int. 2021 Jun;127(6):617-625. doi: 10.1111/bju.15276. Epub 2020 Nov 9. BJU Int. 2021. PMID: 33073457

8

Prognostic role of the systemic immune-inflammation index in upper tract urothelial carcinoma treated with radical nephroureterectomy: results from a large multicenter international collaboration.

Mori K, Resch I, Miura N, Laukhtina E, Schuettfort VM, Pradere B, Katayama S, D'Andrea D, Kardoust Parizi M, Abufaraj M, Fukuokaya W, Collà Ruvolo C, Luzzago S, Knipper S, Palumbo C, Karakiewicz PI, Briganti A, Enikeev DV, Rouprêt M, Margulis V, Egawa S, Shariat SF. Mori K, et al. Among authors: kardoust parizi m. Cancer Immunol Immunother. 2021 Sep;70(9):2641-2650. doi: 10.1007/s00262-021-02884-w. Epub 2021 Feb 16. Cancer Immunol Immunother. 2021. PMID: 33591412 Free PMC article.

9

Fibroblast growth factor receptor: A systematic review and meta-analysis of prognostic value and therapeutic options in patients with urothelial bladder carcinoma.

Kardoust Parizi M, Margulis V, Lotan Y, Mori K, Shariat SF. Kardoust Parizi M, et al. Urol Oncol. 2021 Jul;39(7):409-421. doi: 10.1016/j.urolonc.2021.01.025. Epub 2021 Feb 26. Urol Oncol. 2021. PMID: 33642228

10

Prognostic Impact of Different Gleason Patterns on Biopsy Within Grade Group 4 Prostate Cancer.

Mori K, Sharma V, Comperat EM, Sato S, Laukhtina E, Schuettfort VM, Pradere B, Sari Motlagh R, Mostafaei H, Quhal F, Kardoust Parizi M, Abufaraj M, Karakiewicz PI, Egawa S, Tilki D, Boorjian SA, Shariat SF. Mori K, et al. Among authors: kardoust parizi m. Ann Surg Oncol. 2021 Dec;28(13):9179-9187. doi: 10.1245/s10434-021-10257-x. Epub 2021 Jun 11. Ann Surg Oncol. 2021. PMID: 34117577 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

35 results

Search Page

Filters